INCR
INCR
NASDAQ · Pharmaceuticals

Intercure Ltd

$1.08
-0.01 (-0.92%)
As of Jun 23, 4:20 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,599.1% upside
Low Target $34.56
Average Target $39.95
High Target $63.39
Current Price $1.08
Current
$1.08
Target
$39.95
$34.56 $39.95 avg $63.39
Scenario Analysis
Bear Case
$34.56
3,100.0%
Low target
Base Case
$39.95
+3,599.1%
Avg target
Bull Case
$63.39
+5,769.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$605.00
-99.8% from high
52-Week Low
$225.30
+-99.5% from low
Target vs 52W High
$39.95
-93.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%